Advanced melanoma trial when Keytruda alone is not enough

Publication date: Dec 26, 2018

Patients with metastatic melanoma have faced grim prospects: the American Cancer Society says the five-year survival rate is only 15 percent.

Please signin to view all article content and metadata.

The next generation in scientific exploration and research